Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
This study compared tirzepatide and insulin lispro in patients with type 2 diabetes, finding significant improvements in health-related quality of life with tirzepatide.
This study investigated factors associated with body weight reduction in adults with Type 2 diabetes using tirzepatide, finding that higher doses led to greater weight loss.
This study compared the effects of Tirzepatide and Semaglutide on HbA1c and body weight in Hispanic or Latino patients with Type 2 Diabetes, finding significant reductions with Tirzepatide.
This study evaluated the impact of concomitant metformin use on gastrointestinal adverse events during GLP-1 receptor agonist initiation, finding no increase in adverse events.
Metformin therapy in adults with heart failure and type 2 diabetes.
This post-hoc analysis of the SURPASS-4 trial compared tirzepatide to insulin glargine in participants with type 2 diabetes, finding significant reductions in HbA1c and body weight with tirzepatide.
This Phase 2 trial evaluated the efficacy and safety of Mazdutide in Chinese patients with Type 2 Diabetes, showing significant improvements in glycemic control and weight loss.
This study investigated the effects of liraglutide on plasma GDF15 levels in patients with type 2 diabetes, finding no significant changes in GDF15 levels.
This study analyzed the effects of Tirzepatide on individuals with early-onset Type 2 diabetes, revealing significant improvements in various health markers.
This study investigated the neuroprotective effects of dapagliflozin and liraglutide in patients with type 2 diabetes, highlighting distinct outcomes on brain function.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
